A study by Aldrich et al suggests that local intra-arterial fibrinolysis may be effective in treating central retinal artery occlusion (CRAO). In a nonrandomized trial, 76% of patients receiving intra-arterial tissue plasminogen activator (tPA) had improved visual acuity.
* Jonathan Adler, MD, Emergency Medicine, Harvard Medical School * David Chelmow, MD, Obstetrics & Gynecology, Tufts University School of Medicine * Dirk M Elston, MD, Dermatology, Geisinger Medical Center * Benjamin D Ferguson, MD-PhD Candidate, The University of Chicago Pritzker School of Medicine * John Geibel, MD, DSc, MA, Surgery, Yale University School of Medicine * Harris Gellman, MD, Orthopedic Surgery, University of Miami School of Medicine * George T Griffing, MD, Internal Medicine, St Louis University School of Medicine * Jules E Harris, MD, Oncology, University of Arizona College of Medicine at Tucson * Sherwin SW Ho, MD, Sports Medicine, University of Chicago * Rick Kulkarni, MD, Medical Director, Clinical Procedures and Operative Techniques, Yale University School of Medicine
* Eugene C Lin, MD, Radiology, University of Washington School of Medicine * Consuelo T Lorenzo, MD, Physical Medicine & Rehabilitation, Immanuel Rehabilitation Center * Helmi L Lutsep, MD, Neurology, Oregon Health and Science University * Arlen D Meyers, MD, MBA, Otolaryngology and Facial Plastic Surgery, University of Colorado School of Medicine * Steven F Morris, MD, MSc, FRCSC, Plastic Surgery, Dalhousie University * Thomas H Murray, PhD, Ethics, The Hastings Center * Steven R Neish, MD, SM, Pediatrics, Baylor College of Medicine * Hampton Roy, Sr, MD, Ophthalmology, University of Arkansas for Medical Sciences * Stephen Soreff, MD, Psychiatry, Metropolitan College of Boston University * Thomas M Wheeler, MD, Pathology and Laboratory Medicine, Baylor College of Medicine